Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report
  5. 4 Insider Changes in Ownership
  6. 8-K/A Event Other events
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 8-K Event Other events
  9. 424B5 Offering Prospectus
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 8-K Event Other events
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 8-K Event Other events
  14. 8-K Event Regulation FD disclosure
  15. EFFECT Other Notice of Effectiveness
  16. ARS Other Annual Report to Security Holders
  17. DEFA14A Proxy Proxy Materials
  18. DEF 14A Proxy Proxy Statement
  19. S-3/A Offering Registration Statement
  20. PRE 14A Proxy Proxy Statement (Preliminary)

Page 2 of 34 · 662 filings